Metabolites in Blood and Breath in Metabolic Conditions
NCT07704606 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-08-12
Summary
In patients with inborn errors of metabolism (IEM) and in those requiring a ketogenic diet for the treatment of medical conditions, relevant biochemical analytes are routinely and regularly measured in venous or capillary blood samples. Repeated venipuncture for blood collection is invasive, burdensome, and resource-intensive. As an alternative, capillary blood sampling can provide some relief for the measurement of a limited number of metabolites. Nevertheless, the frequent finger pricks required to obtain capillary blood samples can still be uncomfortable for patients. Therefore, patients could benefit if non-invasive breath measurements were to replace the currently invasive biochemical monitoring methods in the future.
In this study, the usability of metabolite measurements across matrices (venous blood, capillary blood, breath captured by a handheld sensor and breath in a collection bag) in IEM patients, individuals prescribed special health-related diets, and healthy volunteers will be investigated. The usability of a handheld breath sensor for remote monitoring of patients will also be tested. Lastly, exploratory investigations will be performed to identify new disease biomarkers in breath.
Conditions
- Inborn Errors of Metabolism
- Epilepsy (Treatment Refractory)
Interventions
- OTHER
-
Observational Study
no intervention
Sponsors & Collaborators
-
ETH Zurich (Switzerland)
collaborator OTHER -
University Children's Hospital, Zurich
lead OTHER
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-10-01
- Primary Completion
- 2036-10-01
- Completion
- 2037-10-01
More Related Trials
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Patients With Uncontrolled Epilepsy
NCT00001149 ·Status: COMPLETED
-
The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy
NCT04193891 ·Status: TERMINATED
-
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
NCT00552526 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
Ketogenic Diet in Infants With Epilepsy (KIWE)
NCT02205931 ·Status: UNKNOWN ·Phase: PHASE4
-
Ketogenic Diet in Pediatric Intractable Epilepsy
NCT06310954 ·Status: RECRUITING ·Phase: NA
-
Ketogenic Diet Drink Study
NCT03196271 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet for New-Onset Absence Epilepsy
NCT04274179 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
NCT01906398 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multifaceted Assessment of Eating Behaviors, Anthropometric Measurements and Body Composition in Pediatric Patients With Drug-resistant Epilepsy on a Ketogenic Diet and Healthy Children
NCT07714226 ·Status: ACTIVE_NOT_RECRUITING
-
Ketogenic Diet Program for Epilepsy
NCT02497105 ·Status: COMPLETED ·Phase: NA
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
Role of the Gut Microbiota in Pediatric Epilepsy
NCT04705298 ·Status: UNKNOWN ·Phase: PHASE4
-
The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults
NCT03425110 ·Status: UNKNOWN
-
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
NCT04903314 ·Status: COMPLETED ·Phase: PHASE1
-
Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
NCT06700811 ·Status: RECRUITING ·Phase: PHASE1
-
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
NCT02694094 ·Status: ACTIVE_NOT_RECRUITING
-
Dietary Therapy in Children With Refractory Epilepsy
NCT01983163 ·Status: COMPLETED ·Phase: PHASE2
-
The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
NCT02910297 ·Status: WITHDRAWN
-
Nutritional Formulation for Angelman Syndrome
NCT03644693 ·Status: COMPLETED ·Phase: NA
-
Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance
NCT06075485 ·Status: RECRUITING
-
Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy
NCT03014752 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy
NCT02644239 ·Status: UNKNOWN ·Phase: NA
-
Long-term Treatment With the Ketogenic Diet in Epilepsy
NCT04646850 ·Status: ACTIVE_NOT_RECRUITING